2020
DOI: 10.1007/s12282-020-01088-x
|View full text |Cite
|
Sign up to set email alerts
|

Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
22
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(26 citation statements)
references
References 26 publications
3
22
1
Order By: Relevance
“…For example, most previous studies did not identify age as a risk factor and had few younger patients 14 . Additionally, more than 50% of the evidence contributing to BCRL clinical associations is drawn from cross‐sectional or retrospective cohort studies, predominantly among white and older women 2,11,14,33–39 . Of the prospective cohort studies, 90% involve samples sizes <1000, limiting statistical power 2,10,11,40–47 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, most previous studies did not identify age as a risk factor and had few younger patients 14 . Additionally, more than 50% of the evidence contributing to BCRL clinical associations is drawn from cross‐sectional or retrospective cohort studies, predominantly among white and older women 2,11,14,33–39 . Of the prospective cohort studies, 90% involve samples sizes <1000, limiting statistical power 2,10,11,40–47 .…”
Section: Discussionmentioning
confidence: 99%
“…14 Additionally, more than 50% of the evidence contributing to BCRL clinical associations is drawn from cross-sectional or retrospective cohort studies, predominantly among white and older women. 2,11,14,[33][34][35][36][37][38][39] Of the prospective cohort studies, 90% involve samples sizes <1000, limiting statistical power. 2,10,11,[40][41][42][43][44][45][46][47] Our cohort also has a long-term follow-up (i.e., up to largest study (>5000) had short follow-up (6 months after diagnosis).…”
Section: Aggressive Tumor Features Aggressive Clinical Treatment and ...mentioning
confidence: 99%
“…In a large retrospective study by Byun et al a taxane-based regimen was a risk factor for BCRL (p < 0.001) [ 17 ]. Single-centre retrospective studies by Zhu et al and Aoishi et al came to the same conclusion (both p < 0.05) [ 18 , 19 ]. However, the results from two large prospective studies did not support this point of view.…”
Section: Discussionmentioning
confidence: 55%
“…and Aoishi et al came to the same conclusion (both p < 0.05) 14,15 . However, the results from two large prospective studies did not support this point of view.…”
Section: Discussionmentioning
confidence: 56%